Skip to search formSkip to main contentSkip to account menu

fumagillol

Known as: 1-Oxaspiro(2.5)octan-6-ol, 5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-, (3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))- 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
An efficient, two-step construction of highly complex alkaloid-like compounds from the natural product fumagillol is described… 
2009
2009
Inhibition of methionine aminopeptidase-2 (MetAP2) represents a novel approach to antiangiogenic therapy. We describe the… 
2004
2004
Background. Matrix metalloproteinases (MMPs) play a key role in extracellular matrix remodeling events associated with hepatic… 
2004
2004
The present invention is O - (4-methoxy-cinnamoyl) Puma jilrol, O - (3,4,5- trimethoxy-cinnamoyl) Puma jilrol, O - (4-methoxy… 
2001
2001
[reaction: see text]. A new strategy to access the fumagillin/fumagillol skeleton is proposed. An Evans aldolization and a RCM… 
2001
2001
The anti-tumour effect of the angiogenic inhibitor TNP470, σ-(chloro-acetyl-carbamoyl) fumagillol, a synthetic analogue of… 
1999
1999
A 13-step synthesis of (±)-fumagillol (1), the direct precursor of the potent angiogenesis inhibitors TNP-470 and fumagillin… 
1999
1999
The efficacy of cis-diammine dichloroplatinum (CDDP) therapy in combination with continuous administration of angiogenesis… 
1994
1994
Accumulated knowledge regarding the important roles played by angiogenesis in solid tumor growth and metastasis has prompted the… 
1994
1994
Accumulated knwoledge regarding the important roles played by angiogenesis in solid tumor growth and metastasis has prompted the…